These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27522721)

  • 1. [MODERN PROKINETICS AND THEIR ROLE IN THE TREATMENT OF GASTROENTEROLOGICAL PATHOLOGY].
    Sheptulin AA; Belousova IB
    Klin Med (Mosk); 2016; 94(3):178-82. PubMed ID: 27522721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the possibility of using prokinetics in gastroenterology].
    Sheptulin AA; Vize-Khripunova MA
    Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the pharmacology of gastrointestinal prokinetics.
    Tonini M
    Pharmacol Res; 1996; 33(4-5):217-26. PubMed ID: 8938012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
    Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
    Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
    Tonini M; Cipollina L; Poluzzi E; Crema F; Corazza GR; De Ponti F
    Aliment Pharmacol Ther; 2004 Feb; 19(4):379-90. PubMed ID: 14871277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotility medications--now and in the future.
    Karamanolis G; Tack J
    Dig Dis; 2006; 24(3-4):297-307. PubMed ID: 16849857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prokinetics in the Management of Functional Gastrointestinal Disorders.
    Quigley EMM
    Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N; Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroduodenal motility.
    Tack J; Janssen P
    Curr Opin Gastroenterol; 2010 Nov; 26(6):647-55. PubMed ID: 20838344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of prokinetics for the correction of motor and tonic digestive disorders].
    Maev IV; Samsonov AA; Karmanova EA; Ivanchenko EA
    Klin Med (Mosk); 2009; 87(3):49-53. PubMed ID: 19469257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine, but not metoclopramide, abolishes ethosuximide-induced functional gastrointestinal disturbances.
    Sirakov V; Krastev A; Kostadinova I; Turiiski V
    Pharmacology; 2005 Dec; 75(4):187-94. PubMed ID: 16210879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Prokinetics on the Digestive Tract.
    Usai-Satta P; Lai M; Oppia F; Cabras F
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):161-165. PubMed ID: 34455950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic and clinical pharmacology of new motility promoting agents.
    Galligan JJ; Vanner S
    Neurogastroenterol Motil; 2005 Oct; 17(5):643-53. PubMed ID: 16185302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats.
    Yu Y; Chen JH; Li H; Yang Z; Du X; Hong L; Liao H; Jiang L; Shi J; Zhao L; Tan S; Luo H; Huizinga JD
    Neurogastroenterol Motil; 2015 Jul; 27(7):914-28. PubMed ID: 25807879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.